NCT04481256

N/AInterventional

Trials without FDA-defined phases, including trials of devices or behavioral interventions.

View on ClinicalTrials.gov ↗

Timeline

Start date: Oct 1, 2020
Primary completion: Jun 1, 2023
Completion date: Jun 1, 2023
First posted: Jul 22, 2020
Last posted: Jul 24, 2020
Enrollment: 49
Arms / groups: 1 / —
Source: AACT · ingestion pipeline

Sponsors

University of AmsterdamLead sponsor
Maastricht UniversityCollaborator
Utrecht UniversityCollaborator
Isala Clinics, Zwolle, The NetherlandsCollaborator
University of AmsterdamReponsible party - principal investigator
Erasmus University RotterdamCollaborator
Leiden UniversityCollaborator
University of GroningenCollaborator
Rijnstate HospitalCollaborator
Zuyderland Medisch CentrumCollaborator
Netherlands Cancer InstituteCollaborator
Medical Center LeeuwardenCollaborator
Deventer ZiekenhuisCollaborator
Elisabeth-TweeSteden ZiekenhuisCollaborator
Radiotherapeutisch Instituut FrieslandCollaborator
Verbeeten Insituut TilburgCollaborator
Medisch Spectrum TwenteCollaborator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.